中文 | English
Return
Total: 11 , 1/2
Show Home Prev Next End page: GO
Author:(TaeGon KIM)

1.Drainage and seroma formation according to the size of sterile acellular dermal matrix in direct-to-implant breast reconstruction

Tae Hyun KONG ; Taegon KIM ; Jun-Ho LEE

Archives of Aesthetic Plastic Surgery 2022;28(4):130-134

2.Comparison of Energy Requirements of Patients with Brain Injury of the Intensive Care Unit: Indirect Calorimetry vs. Predictive Equations

EunJoo BAE ; SeongSuk KANG ; MiYeon KIM ; JinYoung JANG ; HyunJung LIM ; TaeGon KIM

Journal of Clinical Nutrition 2020;12(2):41-47

3.Comparison of Energy Requirements of Patients with Brain Injury of the Intensive Care Unit: Indirect Calorimetry vs. Predictive Equations

EunJoo BAE ; SeongSuk KANG ; MiYeon KIM ; JinYoung JANG ; HyunJung LIM ; TaeGon KIM

Journal of Clinical Nutrition 2020;12(2):41-47

4.Dual Disruption of DNA Repair by a Novel CHK2 Inhibitor, ART-446, and Olaparib is a Promising Strategy for Triple-Negative Breast Cancer Therapy

Hong-Jun KANG ; Young-Woo KANG ; Ha-Young LEE ; Sojung HA ; Jong Oh KIM ; Woo-Young KIM ; Taegon BAIK

Biomolecules & Therapeutics 2025;33(3):458-469

5.Dual Disruption of DNA Repair by a Novel CHK2 Inhibitor, ART-446, and Olaparib is a Promising Strategy for Triple-Negative Breast Cancer Therapy

Hong-Jun KANG ; Young-Woo KANG ; Ha-Young LEE ; Sojung HA ; Jong Oh KIM ; Woo-Young KIM ; Taegon BAIK

Biomolecules & Therapeutics 2025;33(3):458-469

6.Dual Disruption of DNA Repair by a Novel CHK2 Inhibitor, ART-446, and Olaparib is a Promising Strategy for Triple-Negative Breast Cancer Therapy

Hong-Jun KANG ; Young-Woo KANG ; Ha-Young LEE ; Sojung HA ; Jong Oh KIM ; Woo-Young KIM ; Taegon BAIK

Biomolecules & Therapeutics 2025;33(3):458-469

7.Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

Heeyoung KIM ; Choon Ok KIM ; Hyeonsoo PARK ; Min Soo PARK ; Dasohm KIM ; Taegon HONG ; Yesong SHIN ; Byung Hak JIN

Translational and Clinical Pharmacology 2023;31(1):59-68

8.Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects

Woo Yul LEE ; EunSil OH ; Mengqi CUI ; Choon Ok KIM ; Yeji LIM ; Hunam KIM ; Hyeonsoo PARK ; Sukyong YOON ; Min Soo PARK ; Taegon HONG

Translational and Clinical Pharmacology 2020;28(1):55-65

9.Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers.

Jungsin PARK ; Choon Ok KIM ; Byung Hak JIN ; Seoungwon YANG ; Min Soo PARK ; Taegon HONG

Translational and Clinical Pharmacology 2017;25(4):202-208

10.Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis.

Choon OK KIM ; Sangil JEON ; Seunghoon HAN ; Taegon HONG ; Min Soo PARK ; Young Ran YOON ; Dong Seok YIM

Translational and Clinical Pharmacology 2017;25(1):43-51

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 11 , 1/2 Show Home Prev Next End page: GO